Literature DB >> 21453213

Anxiety, panic disorder and coronary artery disease: issues concerning physical exercise and cognitive behavioral therapy.

Aline Sardinha1, Claudio Gil S Araújo, Gastão Luis Fonseca Soares-Filho, Antonio Egidio Nardi.   

Abstract

Psychological factors such as stress and depression have already been established as primary and secondary cardiovascular risk factors. More recently, the role of anxiety in increasing cardiac risk has also been studied. The underlying mechanisms of increased cardiac risk in panic disorder patients seem to reflect the direct and indirect effects of autonomic dysfunction, as well as behavioral risk factors associated with an unhealthy lifestyle. Implications of the comorbidity between panic and cardiovascular disease include higher morbidity, functional deficits, increased cardiovascular risk, and poor adherence to cardiac rehabilitation or exercise programs. This article probes the most recent evidence on the association between coronary artery disease, anxiety and panic disorder, and discusses the potential role of incorporating regular physical exercise and cognitive behavioral therapy in the treatment of this condition.

Entities:  

Mesh:

Year:  2011        PMID: 21453213     DOI: 10.1586/erc.10.170

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  9 in total

1.  Effects of exercise in renal transplant recipients.

Authors:  Giulio Romano; Eric Lorenzon; Domenico Montanaro
Journal:  World J Transplant       Date:  2012-08-24

2.  Compromised cerebrovascular modulation in chronic anxiety: evidence from cerebral blood flow velocity measured by transcranial Doppler sonography.

Authors:  Hong-Liang Zhang; Zhen-Ni Guo; Ge Yang; Le Yang; Ke Han; Jiang Wu; Yingqi Xing; Yi Yang
Journal:  Neurosci Bull       Date:  2012-11-14       Impact factor: 5.203

3.  Psychiatric disorders and cardiac anxiety in exercising and sedentary coronary artery disease patients: a case-control study.

Authors:  A Sardinha; C G S Araújo; A E Nardi
Journal:  Braz J Med Biol Res       Date:  2012-08-23       Impact factor: 2.590

4.  Cardiorespiratory optimal point: a submaximal exercise variable to assess panic disorder patients.

Authors:  Plínio Santos Ramos; Aline Sardinha; Antonio Egidio Nardi; Claudio Gil Soares de Araújo
Journal:  PLoS One       Date:  2014-08-26       Impact factor: 3.240

5.  Panic disorder and incident coronary heart disease: a systematic review and meta-analysis protocol.

Authors:  Phillip J Tully; Gary A Wittert; Deborah A Turnbull; John F Beltrame; John D Horowitz; Suzanne Cosh; Harald Baumeister
Journal:  Syst Rev       Date:  2015-03-25

6.  Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys.

Authors:  Giulia Ferrannini; Dirk De Bacquer; Pieter Vynckier; Guy De Backer; Viveca Gyberg; Kornelia Kotseva; Linda Mellbin; Anna Norhammar; Jaakko Tuomilehto; David Wood; Lars Rydén
Journal:  Cardiovasc Diabetol       Date:  2021-02-11       Impact factor: 9.951

7.  Epidemiology and prognostic implications of panic disorder and generalized anxiety disorder in patients with coronary artery disease: rationale and design for a longitudinal cohort study.

Authors:  Guillaume Foldes-Busque; Clermont E Dionne; Stéphane Turcotte; Phillip J Tully; Marie-Andrée Tremblay; Paul Poirier; Isabelle Denis
Journal:  BMC Cardiovasc Disord       Date:  2021-01-12       Impact factor: 2.298

8.  Brazilian Portuguese validated version of the Cardiac Anxiety Questionnaire.

Authors:  Aline Sardinha; Antonio Egidio Nardi; Claudio Gil Soares de Araújo; Maria Cristina Ferreira; Georg H Eifert
Journal:  Arq Bras Cardiol       Date:  2013-10-22       Impact factor: 2.000

9.  Asthma and early smoking associated with high risk of panic disorder in adolescents and young adults.

Authors:  Wei-Er Wang; Tsu-Nai Wang; Meng-Huan Wu; Ni-Chi Lin; Mong-Liang Lu; Leanna M W Lui; Roger S McIntyre; Vincent Chin-Hung Chen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2021-07-19       Impact factor: 4.328

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.